NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia

Phase 2

Completed

Conditions: Familial Dysautonomia

Interventions: Dietary Supplement: Phosphatidylserine

First Posted Date: 2014-10-28

Last Posted Date: 2021-02-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 26

Registration Number: NCT02276716

Locations: 🇺🇸
NYU Langone Medical Center, Dyautonomia Center, Suite 9Q, New York, New York, United States

Lifestyle Management of CKD in Obese Diabetic Patients

Not Applicable

Completed

Conditions: Obesity
Type 2 Diabetes
Chronic Kidney Disease (CKD)

Interventions: Behavioral: Social Cognitive Theory
Other: Monitoring

First Posted Date: 2014-10-28

Last Posted Date: 2020-07-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 269

Registration Number: NCT02276742

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Radiation: PBI Radiotherapy 6 Gy
Radiation: PBI Radiotherapy 8 Gy

First Posted Date: 2014-10-28

Last Posted Date: 2025-01-10

Lead Sponsor: NYU Langone Health

Target Recruit Count: 284

Registration Number: NCT02276885

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia

Phase 1

Completed

Conditions: Familial Dysautonomia

Interventions: Dietary Supplement: Kinetin

First Posted Date: 2014-10-24

Last Posted Date: 2019-06-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 15

Registration Number: NCT02274051

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Image Guided Radiotherapy (IGRT) for Prone Partial Breast Irradiation

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: IGRT for prone partial breast irradiation (PBI)

First Posted Date: 2014-10-23

Last Posted Date: 2021-01-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 310

Registration Number: NCT02272400

Locations: 🇺🇸
Laura and Isaac Perlmutter Cancer Center at NYU, New York, New York, United States

Bariatric Lap Band Surgery as a Treatment for Knee Osteoarthritis

Not Applicable

Completed

Conditions: Knee Osteoarthritis

Interventions: Procedure: bariatric lap band surgery

First Posted Date: 2014-10-22

Last Posted Date: 2020-02-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 5

Registration Number: NCT02272218

Locations: 🇺🇸
Center for Musculoskeletal Care, New York, New York, United States

Research on Infarction With Open Arteries Using OCT and CMR

Not Applicable

Active, not recruiting

Conditions: Myocardial Infarction

Interventions: Device: OCT
Procedure: CMR
Drug: contrast agent, Gadolinium

First Posted Date: 2014-10-21

Last Posted Date: 2024-10-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 15

Registration Number: NCT02270359

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Transcranial Stimulation During Sleep to Improve Cognition in Epilepsy

Not Applicable

Withdrawn

Conditions: Epilepsy

Interventions: Device: Transcranial Stimulator

First Posted Date: 2014-10-20

Last Posted Date: 2018-03-15

Lead Sponsor: NYU Langone Health

Registration Number: NCT02268591

Efficacy of TDCS for Treating Working Memory Dysfunction and Depression in Temporal Lobe Epilepsy

Phase 1

Withdrawn

Conditions: Epilepsy

Interventions: Device: Transcranial Direct Current Stimulation
Procedure: Sham Transcranial Direct Current Stimulation

First Posted Date: 2014-10-20

Last Posted Date: 2016-04-15

Lead Sponsor: NYU Langone Health

Registration Number: NCT02268578

Locations: 🇺🇸
Neurology, New York City, New York, United States

Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders

Phase 3

Terminated

Conditions: Lateral Epicondylitis
DeQuervains Tenosynovitis
Trigger Finger
Inflammatory Disease
Tennis Elbow
Tenosynovitis

Interventions: Drug: Dexamethasone
Drug: Ketorolac

First Posted Date: 2014-10-17

Last Posted Date: 2020-11-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 245

Registration Number: NCT02266433

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy